Literature DB >> 19190887

[New strategies for tissue replacement in the head and neck region].

U R Gössler1, K Hörmann.   

Abstract

In recent years there has been an increase in the need for tissue replacement in the head and neck region. The disadvantages of classical reconstructive procedures are donor site morbidity for autologous transplants and the immunogenity of allogenous transplants. Tissue engineering is a promising method for the generation of autologous cartilagenous transplants for plastic and reconstructive surgery for closure of large defects by the use of minimal amounts of material for reconstruction. For this purpose harvested material must be cultivated in suitable culture/carrier systems. One obstacle is the loss of phenotype and function once the cells are detached from their environment (dedifferentiation). Adult mesenchymal stem cells are a valuable cell source for tissue engineering. The underlying strategy of using stem cells is the replacement of functionally compromised cells either by in vitro expanded stem cells or activation of stem cells in the tissue. However, there are still problems regarding valuable markers for cellular differentiation and the controlled differentiation towards a specific phenotype.

Entities:  

Mesh:

Year:  2009        PMID: 19190887     DOI: 10.1007/s00106-008-1866-z

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  87 in total

Review 1.  Tissue engineering with chondrocytes and function of the extracellular matrix (Review).

Authors:  Ulrich Reinhart Goessler; Karl Hörmann; Frank Riedel
Journal:  Int J Mol Med       Date:  2004-04       Impact factor: 4.101

Review 2.  Tissue engineering with adult stem cells in reconstructive surgery (review).

Authors:  Ulrich Reinhart Goessler; Karl Hormann; Frank Riedel
Journal:  Int J Mol Med       Date:  2005-06       Impact factor: 4.101

Review 3.  Growth factors in the extracellular matrix.

Authors:  J Taipale; J Keski-Oja
Journal:  FASEB J       Date:  1997-01       Impact factor: 5.191

Review 4.  Type X collagen: a hypertrophic cartilage-specific molecule.

Authors:  T F Linsenmayer; R D Eavey; T M Schmid
Journal:  Pathol Immunopathol Res       Date:  1988

Review 5.  Diabetes and stem cell researchers turn to the lowly spleen.

Authors:  Shohta Kodama; Miriam Davis; Denise L Faustman
Journal:  Sci Aging Knowledge Environ       Date:  2005-01-19

6.  The progeny of rabbit articular chondrocytes synthesize collagen types I and III and type I trimer, but not type II. Verifications by cyanogen bromide peptide analysis.

Authors:  P D Benya; S R Padilla; M E Nimni
Journal:  Biochemistry       Date:  1977-03-08       Impact factor: 3.162

7.  Dedifferentiated chondrocytes reexpress the differentiated collagen phenotype when cultured in agarose gels.

Authors:  P D Benya; J D Shaffer
Journal:  Cell       Date:  1982-08       Impact factor: 41.582

8.  Effect of transforming growth factor beta1 on chondrogenic differentiation of cultured equine mesenchymal stem cells.

Authors:  A A Worster; A J Nixon; B D Brower-Toland; J Williams
Journal:  Am J Vet Res       Date:  2000-09       Impact factor: 1.156

9.  The chondrogenic potential of human bone-marrow-derived mesenchymal progenitor cells.

Authors:  J U Yoo; T S Barthel; K Nishimura; L Solchaga; A I Caplan; V M Goldberg; B Johnstone
Journal:  J Bone Joint Surg Am       Date:  1998-12       Impact factor: 5.284

10.  Mesenchymal stem cells.

Authors:  A I Caplan
Journal:  J Orthop Res       Date:  1991-09       Impact factor: 3.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.